The Pharmaceutical Landscape in South Africa - Drug Discovery TOE

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This edition of the Drug Discovery TOE depicts the current landscape and the new life sciences trends across the pharmaceutical industry in South Africa. South Africa has a diversified manufacturing industry that focuses on production of pharmaceutical and biotechnology products. Critical programmes were launched by the Department of Trade and Industry (DTI) to promote value adding activities including pharma manufacturing. This study profiles several companies operating at different sites of the value chain. In addition to analyst insights, the corresponding patent scenario is depicted, along with the industry interactions.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: South African healthcare market, South African pharmaceutical industry, immunization, vaccines, diphtheria, tetanus, tuberculosis, hepatitis C virus, hepatitis B virus, pertussis, hepatitis B, haemophilus influenzae b, DTP-HepB-Hib, HIV, AIDS, affordable medicines, generics, biosimilars, over the counter drugs

Table of Contents

The Pharmaceutical Landscape in South Africa - Drug Discovery TOETrend OverviewKey Facts and Findings: Patents as the Vital ComponentThe Pharmaceutical Landscape in South AfricaThe Pharmaceutical Value Chain in South AfricaTechnology ProfilesWorld Class and Locally Relevant Vaccines Access to Innovative Medicines, Services, and Technologies in South AfricaSucceeding in the South African Generics MarketAddressing South African Pharmaceutical Market RegulationsPatient Focused Healthcare to Strive for ExcellenceCreating a Biotechnology Infrastructure in South AfricaExtensive Range of Generics for AilmentsAppendixPatent AnalysisPatent Analysis (continued)Patent Analysis (continued)Industry InteractionsIndustry Interactions




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.